HD-OPM Archive
Topics › PCSK9, ezetimibe & newer drugs

Economist: gene-editing drugs for cardiovascular disease are moving from lab to clinic

Louis Nervegna · Sep 16, 2024 · ♥ 10 reactions · 7 comments · original Facebook post
PCSK9, ezetimibe & newer drugsCardiovascular disease: the big picture
AI summary & key facts

Louis shares an Economist article stating gene-editing medicines are advancing rapidly and a new class tackling cardiovascular disease and cancer should gather pace in the coming year. The excerpt gives no trial details.

Gene-editing technologies to treat cardiovascular disease will soon become a reality.

(See comments for a link that bypasses the paywall.)

Research cited

Scientists have already used gene editing to improve some people’s vision. They also appear able to cure sickle-cell anaemia. A new class of medicines will gather pace in the coming year, tackling cardiovascular disease and cancer

#cardiovasculardisease#cardiovascular#cancer
← newer: Statins may lower risk of certain cancers and synergize witholder: Keto causes bigger temporary insulin resistance than statins →